Effectiveness of Digital Rehabilitation (SIMPLI.REHAB) in Hand Arthritis
1 other identifier
interventional
35
1 country
1
Brief Summary
This study investigates the effectiveness of SIMPLI.REHAB, a digital tool employed as an interface for administering occupational rehabilitation programs to patients diagnosed with Rheumatoid and Psoriatic Arthritis. Both of these conditions are inflammatory joint disorders capable of causing significant morphofunctional alterations in the hands, especially in their advanced stages. The introduction of digital technology emerges as a complementary tool when implementing rehabilitation programs. Utilizing a prospective, longitudinal, single-blinded experimental study, 35 patients will be allocated into two groups: one receiving a complementary digital intervention through SIMPLI.REHAB and the other through a conventional rehabilitation program. Each group consists of six patients and the program spans seven weeks, focusing on therapeutic exercises, training in manual dexterity, and motor coordination, among other interventions, led by a Physiatrist. The study intends to measure outcomes based on functionality scores, pain, disease activity, joint range, grip, pinch strength, and manual dexterity, both before and after each intervention, in order to ascertain the efficacy of integrating dynamic content through the digital tool SIMPLI.REHAB, as a supplementary resource in occupational rehabilitation programs. The potential limitations of the study include potential losses of follow-up and difficulties in assessing adherence to the digital tool precisely. Nonetheless, the digital tool aims to augment functional gains in rehabilitation programs by providing patients with accessible dynamic content of home-based strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2023
CompletedFirst Posted
Study publicly available on registry
October 11, 2023
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedApril 30, 2024
April 1, 2024
5 months
September 24, 2023
April 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Disabilities of the Arm, Shoulder and Hand (DASH) Score
Hand functionality in basic and instrumental daily life activities, occupational and artistic or sports activities, through the score in the Disabilities of the Arm, Shoulder and Hand (DASH) 30-item questionnaire, calculated before and after the intervention. For each question, the patient rates on a 5-point Likert scale. The total score will range from 0 (no disability) to 100 (severe disability). It is a valid and reliable questionnaire (Pearson r \> 0.70; ICC(2,1) = 0.96), with a minimal clinically important difference ranging between 10.83 and 15. (33, 37, 38).
Average of 7 weeks
QuickDASH Outcome Measure
Shortened version of the DASH questionnaire which includes 11 items for clinical and functional evaluation of the upper limb. The QuickDASH questionnaire assesses an individual's ability to complete daily life activities, the ability to bear load, as well as the intensity of symptoms. It is also a valid and reliable questionnaire (Pearson r \> 0.70; ICC(2,1) = 0.90), with the minimal clinically important difference ranging between 15.91 and 20.
Average of 7 weeks
Secondary Outcomes (3)
Number of Participants with New Osteoarticular Deformities
Average of 7 weeks
Rate of Rescue Medications Usage
Average of 7 weeks
Number of Participants with Assistive Devices
Average of 7 weeks
Other Outcomes (8)
Numeric Pain Scale
Average of 7 weeks
Range of Motion
Average of 7 weeks
Muscular Strength
Average of 7 weeks
- +5 more other outcomes
Study Arms (2)
Digital Intervention Group
EXPERIMENTALThis group incorporates the SIMPLI.REHAB digital tool as a complementary strategy for a rehabilitation program, including flexibility exercises and muscle strengthening, manual dexterity and motor coordination training, thermotherapy, and education on joint protection principles.
Conventional Intervention Group
ACTIVE COMPARATORThis group follows a conventional rehabilitation program delivered in a more traditional, non-digital manner to serve as a comparison to assess the superiority of the experimental intervention using SIMPLI.REHAB digital tool.
Interventions
Participants in this arm will undergo an in-person rehabilitation program coordinated by a Physiatrist and will be able to access home-based rehabilitation strategies through dynamic content provided by SIMPLI.REHAB digital tool.
Participants in this arm will undergo an in-person rehabilitation program coordinated by a Physiatrist and will be given home-based strategies in a printed paper brochure.
Eligibility Criteria
You may qualify if:
- " Must be referred patients from the Rheumatology Service of CHVNG/E. " Age 18 or older. " Must have a clinical diagnosis of either rheumatoid arthritis or psoriatic arthritis by a Rheumatology specialist, as per the diagnostic criteria of the American College of Rheumatology.
- " Must present pain, joint stiffness, joint instability, or osteoarticular deformities in the joints of the wrist, hand, and fingers.
- " Must have a functional impact with a QuickDASH score \> 31.5. " Must be capable of using the SIMPLI.REHAB app on a smartphone with internet connectivity.
- " Must possess digital literacy allowing the use of the app. " Must have the ability to understand and provide informed consent.
You may not qualify if:
- "Presence of other medical conditions that might interfere with participation or interpretation of results, such as: neoplasms, other systemic autoimmune diseases, diabetic polyneuropathy and/or uncontrolled diabetes " Having had local surgery on the joint of the wrist, hand, and fingers or a history of fracture in the last 6 months.
- " History of intra-articular or intramuscular corticoanesthetic infiltration in the previous 4 weeks.
- " Inability to perform hand exercises due to significant understanding, cognitive, or physical limitation.
- " Participation in an occupational rehabilitation program during the study period or in the last 6 months.
- " Severe hearing loss or visual impairment. " Undergoing other types of therapies or localized interventions in the hand and fingers during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Hospitalar de Vila Nova de Gaia-Espinho, E.P.E.
Porto, Vila Nova De Gaia, 4434-502, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eugénio M Gonçalves, MD
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
- STUDY DIRECTOR
Ana M Campolargo, MD
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 24, 2023
First Posted
October 11, 2023
Study Start
July 1, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
April 30, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share